Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
Question: Is there a Suboxone class action lawsuit?
Answer: No, there is not currently a Suboxone class action lawsuit in 2024. Individual personal injury claims associated with dental issues from taking Suboxone are being consolidated into multi-district litigation within the Northern District of Ohio.
On this page, we’ll discuss this question in further depth, differences between the Suboxone MDL and class action lawsuits, dental problems in the Suboxone litigation, and much more.
The primary allegations in the Suboxone lawsuits involve:
If you have experienced significant dental issues after using Suboxone, you may be eligible to file a lawsuit and seek compensation for your injuries.
Contact TruLaw to receive a free case evaluation and learn if you qualify to join another filing in the Suboxone tooth decay lawsuit today.
Multidistrict litigation (MDL) and class action lawsuits are two distinct legal mechanisms for handling multiple similar cases, such as Suboxone tooth decay lawsuits.
The key differences between MDLs and class action lawsuits include:
MDLs allow for more personalized handling of each case, while class actions treat all plaintiffs as a single entity.
This distinction is crucial for understanding the nuances of the Suboxone tooth decay litigation.
MDL 3092 offers a more individualized approach compared to class action lawsuits.
It provides plaintiffs with the opportunity to maintain their own legal representation and pursue their cases based on personal circumstances.
MDL 3092, which consolidates Suboxone lawsuits, differs from a class action in several ways:
In contrast, class actions involve a single lawsuit representing the entire group of plaintiffs, with limited individual control.
The Suboxone lawsuit MDL structure allows for a more tailored approach to each plaintiff’s unique circumstances.
Consolidating Suboxone teeth lawsuits through an MDL offers several advantages for plaintiffs and the legal system.
The benefits of the Suboxone MDL include:
By grouping similar cases, the MDL promotes efficiency and reduces the risk of contradictory decisions.
This consolidation can encourage defendants to consider broad settlement options for Suboxone tooth decay lawsuits.
The Suboxone tooth decay litigation, known as MDL-3092, was established to address the growing number of federal Suboxone lawsuits alleging dental injuries associated with prescribed Suboxone use.
This consolidation aims to streamline the legal process and ensure consistent outcomes for plaintiffs who have suffered severe tooth decay.
In August 2023, the Judicial Panel on Multidistrict Litigation (JPML) approved the creation of MDL-3092 in the Northern District of Ohio.
This centralization brings together Suboxone tooth decay lawsuits from multiple federal districts under the supervision of a single judge.
The Suboxone lawsuit MDL was established to handle the increasing number of lawsuits efficiently and consistently.
Reasons for creating the MDL include:
By consolidating these cases, the court can better manage the litigation and ensure fair outcomes for all parties involved.
The Suboxone lawsuits consolidated in MDL-3092 focus on dental injuries allegedly caused by the use of Suboxone sublingual films, medication physicians prescribed for opioid addiction treatment.
Plaintiffs claim that prescribed Suboxone has caused significant dental injuries that require extensive and costly treatment.
Many plaintiffs have experienced severe dental health problems as a result of using Suboxone.
These complications have greatly impacted their quality of life and financial stability.
Plaintiffs in the Suboxone MDL report a range of dental problems, including:
These issues can lead to significant pain, difficulty eating, and the need for expensive dental procedures.
Plaintiffs allege that the manufacturers of prescription Suboxone film failed to warn about these risks adequately.
Suboxone sublingual films, which contain buprenorphine and naloxone, are designed to dissolve under the tongue.
However, prolonged contact with the teeth and gums can lead to dental injuries over time.
Factors that may contribute to Suboxone-related dental issues include:
Plaintiffs argue that the manufacturers should have known about these risks and provided clearer warnings to patients and healthcare providers.
The Suboxone tooth decay litigation aims to hold the manufacturers accountable for these alleged harms.
Since the formation of MDL-3092, the number of Suboxone tooth decay lawsuits has continued to grow.
This increase in cases reflects the widespread use of prescription Suboxone film for opioid addiction treatment and the growing awareness of the potential dental injuries associated with the medication.
In the months following the creation of the Suboxone lawsuit MDL, the number of lawsuits has surged.
This rapid growth can be attributed to several factors:
As more individuals learn about the potential link between Suboxone sublingual films and severe tooth decay, the number of lawsuits is expected to continue rising.
As of July 2024, the Suboxone tooth decay litigation is still in its early stages.
Recent developments in the litigation include:
The court is working to streamline the process and ensure that all plaintiffs’ Suboxone tooth decay claims are fairly represented.
As the MDL progresses, additional developments and potential settlement discussions may arise.
Multidistrict litigation is a complex process that involves several key stages.
Understanding these stages and the potential outcomes for plaintiffs is essential for those considering joining the Suboxone tooth decay litigation.
The progression of MDLs usually involves several distinct phases designed to streamline the handling of complex cases.
These stages help ensure that the litigation process is efficient and fair for all parties involved.
The Suboxone MDL will likely follow a similar path to other MDLs, which typically includes:
Each stage plays a crucial role in the progression of the litigation and can impact the ultimate outcomes for plaintiffs in Suboxone teeth lawsuits.
Plaintiffs in the Suboxone lawsuit MDL may face a range of potential outcomes, depending on the strength of their individual cases and the overall trajectory of the litigation.
Possible results include:
The outcome of the Suboxone tooth decay litigation will depend on various factors, including the evidence presented, legal arguments, and the defendant’s willingness to settle.
As the Suboxone tooth decay litigation moves forward, it is essential to consider its potential future and its impact on prescribed Suboxone users and manufacturers.
Without a class action lawsuit, the MDL remains the primary legal mechanism for addressing Suboxone-related dental injuries.
Given the growing awareness of the potential link between Suboxone sublingual films and severe tooth decay, it is likely that additional lawsuits will continue to join the MDL in the coming months and years, depending on the applicable statute of limitations.
Factors that may influence the number of future Suboxone lawsuits include:
As more information emerges and the litigation progresses, Suboxone tooth decay lawsuits may continue to rise.
The Suboxone tooth decay litigation has the potential to significantly impact both prescribed Suboxone users and manufacturers in the future.
For users, the litigation may:
The MDL could result in substantial financial liabilities and reputational damage for manufacturers.
The outcome of the litigation may also influence future research, development, and marketing of similar medications used in opioid addiction treatment.
TruLaw remains committed to providing accurate and up-to-date information about the Suboxone tooth decay litigation and its implications for patients and the legal system.
As the Suboxone lawsuit MDL progresses, TruLaw will continue to offer comprehensive coverage, analysis, and resources for those affected by Suboxone-related dental injuries.
Our team will closely monitor the litigation and provide timely updates on significant developments, potential settlements, and outcomes.
By staying informed about the Suboxone tooth decay litigation, patients can make better decisions about their legal rights and options.
Suboxone lawyers at TruLaw aim to be a trusted source of information and support throughout the litigation process for those who have suffered severe tooth decay due to physician-prescribed Suboxone film used in opioid addiction treatment.
Plaintiffs in the Suboxone lawsuits report various dental problems, including tooth decay, cavities, gum disease, and tooth loss.
These dental injuries allegedly stem from the use of Suboxone sublingual films prescribed for opioid addiction treatment.
Suboxone sublingual films are designed to dissolve under the tongue, leading to prolonged contact with teeth and gums.
This extended exposure, combined with the medication’s acidic nature and the dry mouth it can cause, may contribute to dental injuries over time.
As of July 2024, the Suboxone tooth decay litigation is still in its early stages, with the number of lawsuits continuing to grow.
Recent developments include the appointment of lead counsel, the establishment of a master complaint, and ongoing discovery and pretrial proceedings.
The Suboxone MDL differs from a class action lawsuit in that each plaintiff retains their legal representation and maintains more control over their case.
MDLs allow for more personalized handling of each lawsuit, while class actions treat all plaintiffs as a single entity.
Suppose you have experienced dental problems like tooth decay or other dental injuries after taking physician-prescribed Suboxone sublingual films.
In that case, it is essential to consult with a qualified Suboxone lawyer to discuss your legal options.
They can help determine if you can file a Suboxone lawsuit and join the ongoing MDL.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
You can learn more about the Suboxone Lawsuit by visiting any of our pages listed below:
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.
Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.
Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?